FDA Documents of Taro Pharmaceuticals Inc.
Taro Pharmaceuticals Inc. is an organization that has been audited by the FDA 9 times between 2001 and 2022 across all 1 sites.
Documents
FDA 483 Taro Pharmaceuticals Inc., Brampton | 2022
Out-of-stock
Issued on: Sep 16, 2022
Human Drug Form 483
FDA 483 Taro Pharmaceuticals Inc., Brampton | 2019
Out-of-stock
Issued on: May 3, 2019
Human Drug Form 483
FDA 483 Taro Pharmaceuticals Inc., Brampton | 2017
Out-of-stock
Issued on: Jan 20, 2017
Human Drug Form 483
FDA 483 Taro Pharmaceuticals Inc., Brampton | 2014
Out-of-stock
Issued on: Feb 28, 2014
Human Drug Form 483
FDA 483 Taro Pharmaceuticals Inc., Brampton | 2011
Out-of-stock
Issued on: Feb 11, 2011
Human Drug Form 483
FDA 483 Taro Pharmaceuticals Inc., Brampton | 2008
Out-of-stock
Issued on: Jul 31, 2008
Human Drug Form 483
FDA Investigators(12)
- Marian E. Ramirez, FDA Investigator
- Carrie A. Hughes, FDA Investigator
- Felix Maldonado, FDA Investigator
- Tajah L. Blackburn, FDA Investigator
- Steven D. Kehoe, FDA Investigator
- Michael R. Klapal, FDA Investigator
- Marie A. Fadden, FDA Investigator
- Daryl A. Dewoskin, FDA Investigator
- Marianela Aponte Cruz, FDA Investigator
- Aponte Cruz, Marianela, FDA Investigator
- David J. Hafner, FDA Investigator
- Arlene M. Badillo, FDA Investigator